Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 6/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.32 |
| ▸ | CPN1 | P15169 | 2/20 | 0.31 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16144637 | 1.00 | SLC6A2 (0.32) | SLC6A2SLC6A4SLC6A3CPN1CPB2 | |
| SCHEMBL19045386 | 0.86 | CPN1 (0.36) | CPN1CPB2 | |
| Hydrochloric Acid SCHEMBL19030022 | 0.84 | CPN1 (0.35) | SLC6A2SLC6A4SLC6A3CPN1CPB2 | |
| SCHEMBL13326697 | 0.81 | — | — | |
| SCHEMBL28364127 | 0.77 | SLC6A2 (0.32) | SLC6A2SLC6A4SLC6A3CPN1CPB2 | |
| SCHEMBL5760440 | 0.77 | SLC6A2 (0.32) | SLC6A2SLC6A4SLC6A3CPN1CPB2 | |
| SCHEMBL29272164 | 0.76 | SLC6A2 (0.33) | SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL20730995 | 0.75 | — | — | |
| SCHEMBL20898998 | 0.75 | — | — | |
| SCHEMBL20898999 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050119231-A1 | Quinolone antibacterial agents | ELLSWORTH EDMUND L (US) | 2005-06-02 | — | — | US | disclosed |
| US-20050107423-A1 | Quinolone antibacterial agents | ELLSWORTH EDMUND L (US) | 2005-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119231-A1 | Quinolone antibacterial agents | NQO2, MRPL21, TOP1 | SLC6A2 2565/4885SLC6A4 3457/4885SLC6A3 2888/4885 |
| US-20050107423-A1 | Quinolone antibacterial agents | NQO2, MRPL21, TOP1 | SLC6A2 2565/4885SLC6A4 3457/4885SLC6A3 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.